Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TET2, tumor control, and CAR T cell hyperproliferation

Trends in cancer(2023)10.1016/j.trecan.2023.04.009Source: DataRank Database

TET2, tumor control, and CAR T cell hyperproliferation is a research paper published in Trends in cancer (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.11)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

Patrick G. Hogan ORCID,Barsha Dash

Live enrichment

PubMed:37173187 PMC:PMC10812842 OpenAlex:https://openalex.org/W4376139740

NIAID

Grant: AI040127

NIAID

Grant: AI109842

Cancer Research Institute

Grant: CRI4681

NIAID NIH HHS

Grant: R01 AI040127

NIAID NIH HHS

Grant: R56 AI109842

NIAID NIH HHS

Grant: R01 AI109842

FWCI

0.11

Citation Percentile

0.4%

Citation Trend

2024

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10812842/pdf/nihms-1959911.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000730?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000730?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10812842

Fields of Study

CAR-T cell therapy researchImmune Cell Function and InteractionCRISPR and Genetic EngineeringHumansT-LymphocytesReceptors, Chimeric AntigenImmunotherapy, AdoptiveNeoplasmsCell ProliferationDNA-Binding ProteinsDioxygenases

MeSH Terms

Receptors, Chimeric AntigenDNA-Binding ProteinsHumansNeoplasmsT-LymphocytesImmunotherapy, AdoptiveCell ProliferationDioxygenases

Keywords

Chimeric antigen receptorPersistence (discontinuity)ReceptorCell biologyCancer researchChemistryBiologyT cellImmunologyBiochemistryImmune systemLymphocyteclonalCarTet2Hyperproliferation

Sustainable Development Goals

SDG 0: Good health and well-being